Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $5.90 USD
Change Today -0.04 / -0.67%
Volume 2.2M
ARRY On Other Exchanges
As of 5:20 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ron Squarer BSc (Biochemistry), MBA

Chief Executive Officer and Director,Array BioPharma Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Ron Squarer, BSc (Biochemistry), MBA, has been the Chief Executive Officer of Array BioPharma, Inc. since April 2012. Mr. Squarer served as Corporate Vice President of Global Strategy & Business Development at Hospira Australia Pty Ltd. since February 1, 2007. He served as the Chief Commercial Officer and Senior Vice President of Hospira Inc., since February 2010. Mr. Squarer served as Senior Vice President of Global Marketing & Corporate Development at Hospira Inc. ...

Read Full Background

Corporate Headquarters*

3200 Walnut Street
Boulder, Colorado 80301

United States

Phone: 303-381-6600
Fax: 303-449-5376

Board Members Memberships*

Chief Executive Officer and Director


Bachelor's Degree
University of California Berkeley
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$548,750

Stock Options*

All Other Compensation$62,675
Exercisable Options587,500
Exercisable Options Value$475,000
Unexercisable Options1,187,500
Unexercisable Options Value$475,000
Total Value of Options$950,000
Total Number of Options1,775,000

Total Compensation*

Total Annual Cash Compensation$953,250
Total Short Term Compensation$548,750
Other Long Term Compensation$62,675
Total Calculated Compensation$2,190,269
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARRY:US $5.90 USD -0.04


Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer, President and Principal Financial Officer
Arena Pharmaceuticals, Inc.
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARRAY BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at